Position in PCVX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$26,316,787
-$2,846,123 QoQ
Shares Held
452,723
-9.8% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#49
of 329 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. PCVX ranks #17 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in PCVX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,316,787 | 452,723 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $29,162,910 | 501,857 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,354,575 | 549,514 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,342,409 | 314,892 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,649,621 | 450,619 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,338,125 | 220,819 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $24,849,093 | 303,556 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $29,143,420 | 255,040 | Shares | Other | 2024-11-05 | |
| 2024-06-30 | $23,220,533 | 307,516 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $19,186,570 | 280,875 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $23,826,759 | 379,407 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $21,969,779 | 430,949 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $23,087,461 | 462,304 | Shares | Other | 2023-07-27 | |
| 2023-03-31 | $14,738,971 | 393,249 | Shares | Other | 2023-05-02 | |
| 2022-12-31 | $3,246,838 | 67,713 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $1,344,480 | 56,020 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,602,188 | 73,630 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,149,591 | 89,010 | Shares | Sole | 2022-05-04 | |
| 2020-09-30 | $251,936 | 5,102 | Shares | Sole | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||